- Daphne Zohar
-
Daphne Zohar is an Israeli-American entrepreneur. She is the founder and managing partner of PureTech Ventures, a venture creation firm that develops discoveries from academic labs into treatments for human health.
In 2003, she was named to the MIT Technology Review TR100 as one of the top 100 innovators in the world under the age of 35.[1][2] In 2010 she was selected by BioWorld, a widely-read biotechnology industry publication, as one of 28 leaders predicted to be the "movers and shakers" of the biotechnology industry over the next twenty years. [3]
PureTech and Zohar are also known for the creation of Enlight Biosciences, a first-of-its-kind collaboration between six major pharmaceutical companies (Abbott, Merck, Johnson & Johnson, Pfizer, Lilly, and Novartis).[4][5][6][7]
Zohar has also been vocal in criticizing the venture industry for its treatment of entrepreneurs.[8]
References
- ^ "2003 Young Innovators Under 35". Technology Review. 2003. http://www.technologyreview.com/tr35/?year=2003. Retrieved August 15, 2011.
- ^ http://www.technologyreview.com/tr35/Profile.aspx?TRID=339
- ^ "The Future is Here: Who Will Shape Biotech Over the Next 20 Years? Bioworld Says...", Bioworld 20th Anniversary Edition, p. 24
- ^ http://online.wsj.com/article/SB121565639890841655.html
- ^ http://www.xconomy.com/boston/2009/06/15/novartis-backing-enlight-biosciences/
- ^ http://www.nature.com/nbt/journal/v26/n9/full/nbt0908-960.html
- ^ http://www.merck.com/licensing/our-partnership/innovation-spotlight.html
- ^ http://www.xconomy.com/national/2009/08/24/venture-model-makeover-diet-plan-step-one/
External links
Categories:- Living people
- American health care businesspeople
- TR35 winners
Wikimedia Foundation. 2010.